Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Imaging approaches with advanced prostate cancer: techniques and timing.

Leung D, Krishnamoorthy S, Schwartz L, Divgi C.

Can J Urol. 2014 Apr;21(2 Supp 1):42-7. Review.

2.

Current management of advanced and castration resistant prostate cancer.

Gomella LG, Petrylak DP, Shayegan B.

Can J Urol. 2014 Apr;21(2 Supp 1):1-6.

3.

Imaging in prostate cancer.

Abdellaoui A, Iyengar S, Freeman S.

Future Oncol. 2011 May;7(5):679-91. doi: 10.2217/fon.11.43. Review.

PMID:
21568683
4.

[EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer].

Mottet N, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, Schmid HP, van der Kwast T, Wiegel T, Zattoni F, Heidenreich A.

Actas Urol Esp. 2011 Nov-Dec;35(10):565-79. doi: 10.1016/j.acuro.2011.03.011. Epub 2011 Jul 14. Spanish.

PMID:
21757258
5.

Imaging prostate cancer: current and future applications.

el-Gabry EA, Halpern EJ, Strup SE, Gomella LG.

Oncology (Williston Park). 2001 Mar;15(3):325-36; discussion 339-42. Review.

6.

Which metabolic imaging, besides bone scan with 99mTc-phosphonates, for detecting and evaluating bone metastases in prostatic cancer patients? An open discussion.

Bombardieri E, Setti L, Kirienko M, Antunovic L, Guglielmo P, Ciocia G.

Q J Nucl Med Mol Imaging. 2015 Dec;59(4):381-99. Epub 2015 Sep 3. Review.

7.

New clinical imaging modalities in prostate cancer.

Ross R, Harisinghani M.

Hematol Oncol Clin North Am. 2006 Aug;20(4):811-30. Review.

PMID:
16861116
8.

Radionuclide based imaging of prostate cancer.

Mease RC.

Curr Top Med Chem. 2010;10(16):1600-16. Review.

PMID:
20583988
9.

Imaging modalities for prostate cancer.

Fütterer JJ, Barentsz J, Heijmijnk ST.

Expert Rev Anticancer Ther. 2009 Jul;9(7):923-37. doi: 10.1586/era.09.63. Review.

PMID:
19589032
10.

EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.

Mottet N, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, Schmid HP, Van der Kwast T, Wiegel T, Zattoni F, Heidenreich A.

Eur Urol. 2011 Apr;59(4):572-83. doi: 10.1016/j.eururo.2011.01.025. Epub 2011 Jan 25.

PMID:
21315502
11.

Update on magnetic resonance imaging, ProstaScint, and novel imaging in prostate cancer.

Brassell SA, Rosner IL, McLeod DG.

Curr Opin Urol. 2005 May;15(3):163-6. Review.

PMID:
15815192
12.

Prostate cancer imaging: what the urologist wants to know.

Talab SS, Preston MA, Elmi A, Tabatabaei S.

Radiol Clin North Am. 2012 Nov;50(6):1015-41. doi: 10.1016/j.rcl.2012.08.004. Review.

PMID:
23122036
13.

Bone imaging in prostate cancer.

Dotan ZA.

Nat Clin Pract Urol. 2008 Aug;5(8):434-44. doi: 10.1038/ncpuro1190. Review.

PMID:
18682719
14.

Imaging and evaluation of patients with high-risk prostate cancer.

Bjurlin MA, Rosenkrantz AB, Beltran LS, Raad RA, Taneja SS.

Nat Rev Urol. 2015 Nov;12(11):617-28. doi: 10.1038/nrurol.2015.242. Epub 2015 Oct 20. Review.

PMID:
26481576
15.

[Diagnostic imaging of the prostate cancer].

Mocarska A, Starosławska E, Iwonna ZC, Brzozowska A, Łosicki M, Stasiewicz D, Burdan F.

Pol Merkur Lekarski. 2012 Dec;33(198):357-63. Review. Polish.

PMID:
23437709
16.

The evolution of imaging in advanced prostate cancer.

Manyak MJ, Javitt M, Kang PS, Kreuger WR, Storm ES.

Urol Clin North Am. 2006 May;33(2):133-46, v. Review.

PMID:
16631452
17.

Imaging in prostate carcinoma.

Zukotynski K, Haider MA.

Hematol Oncol Clin North Am. 2013 Dec;27(6):1163-87, vii-viii. doi: 10.1016/j.hoc.2013.08.003. Review.

PMID:
24188257
18.

Imaging prostate cancer.

Jung AJ, Westphalen AC.

Radiol Clin North Am. 2012 Nov;50(6):1043-59. doi: 10.1016/j.rcl.2012.08.001. Review.

PMID:
23122037
19.

One-step TNM staging of high-risk prostate cancer using magnetic resonance imaging (MRI): toward an upfront simplified "all-in-one" imaging approach?

Pasoglou V, Larbi A, Collette L, Annet L, Jamar F, Machiels JP, Michoux N, Vande Berg BC, Tombal B, Lecouvet FE.

Prostate. 2014 May;74(5):469-77. doi: 10.1002/pros.22764. Epub 2013 Dec 24.

20.

Developing imaging strategies for castration resistant prostate cancer.

Fox JJ, Morris MJ, Larson SM, Schöder H, Scher HI.

Acta Oncol. 2011 Jun;50 Suppl 1:39-48. doi: 10.3109/0284186X.2011.572914.

Supplemental Content

Support Center